Renibus Therapeutics Raises $33 Million Bridge Financing To Advance Its Portfolio Of Cardiorenal Product Candidates
Amount Raised
$33 Million
Round Type
Funding Round
SouthlakeBiotechnologyHealthcareHealth CareMedicalTherapeuticsBiopharmaDescription
Renibus Therapeutics, Inc., ("Renibus"), a clinical-stage biotechnology company developing breakthrough products for cardiorenal diseases, today announced a $33 million bridge financing consisting of a $23 million SAFE (Simple Agreement for Future Equity) offering and $10 million pursuant to the first tranche of a $30 million term loan with Oxford Finance LLC ("Oxford").
Quick answer
Renibus Therapeutics raised $33 Million in a Funding Round round, dated November 14, 2022. Renibus Therapeutics is based in Southlake, Texas, United States.
- How much did Renibus Therapeutics raise?
- Renibus Therapeutics raised $33 Million in a Funding Round round on November 14, 2022.
- What does Renibus Therapeutics do?
- Renibus is a clinical-stage biopharmaceutical company focused on preventing disease progression, protecting against organ damage, and improving outcomes in cardiorenal diseases.
- Where is Renibus Therapeutics based and how big is it?
- Renibus Therapeutics is based in Southlake, Texas, United States. Fundz records about 332 employees.
- Who are the decision-makers at Renibus Therapeutics?
- Fundz holds 1 contact at Renibus Therapeutics, including the Co-Founder, President and COO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Medical around the same time
Companies in the same sectors as Renibus Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Parabilis Medicines raised $178M on November 17, 2022.
- Os Therapies raised $2M on November 16, 2022.
- NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
- MBX Biosciences, Inc. raised $47M on November 7, 2022.
Who to call at Renibus Therapeutics, and when
A new round usually means Renibus Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Renibus Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Renibus Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Renibus Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Renibus Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Renibus Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.